01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes

Alexandre Benjo MD1,†, Rhanderson N. Cardoso MD2,†,*, Tyrone Collins MD, FACC, FSCAI1, Daniel Garcia MD2, Francisco Y. Macedo MD3, Georges El-Hayek MD4, Girish Nadkarni MD5, Emad Aziz DO, FACC4 andJ. Stephen Jenkins MD, FACC, FSCAI1

Introduction: Clinical trials have shown a short-term benefit of drug-eluting stents (DES) compared to vascular brachytherapy (VBT) for treatment of in-stent restenosis (ISR). The long-term benefits of DES vs. VBT are conflicting in the literature. This study aimed to do a meta-analysis of long-term outcomes of DES compared to VBT for treatment of ISR.

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Intravascular ultrasound predictors of acute side branch occlusion in coronary artery bifurcation lesions just after single stent crossover

Nobuo Sakamoto MD*, Yasuto Hoshino MD, Hiroyuki Mizukami MD, Koichi Sugimoto MD, Takayoshi Yamaki MD, Hiroyuki Kunii MD, Kazuhiko Nakazato MD, Hitoshi Suzuki MD, Shu-ichi Saitoh MD andYasuchika Takeishi MD

Objectives: We aimed to assess the intravascular ultrasound (IVUS) predictors of acute side branch (SB) occlusions just after single stent crossover in percutaneous coronary intervention (PCI) for coronary bifurcation lesions.

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent

Jorge Belardi MD1,*, Ganesh Manoharan MD3, Mariano Albertal MD, PHD2, Petr Widimský MD, DSC4, Franz-Joseph Neumann MD5, Sigmund Silber MD, PHD6, Martin B. Leon MD, MSC7 andShigeru Saito MD8

Aims: To evaluate the rate of clinical events and bleeding risk according to age in patients undergoing percutaneous coronary intervention (PCI) with a new-generation drug-eluting stent (DES) enrolled in the RESOLUTE Global Clinical Program.

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study

Cristina Ciuca MD1, Giuseppe Tarantini MD, PhD2, Azeem Latib MD3,4, Valeria Gasparetto MD2, Carlo Savini MD5, Marco Di Eusanio MD5, Massimo Napodano MD2, Francesco Maisano MD6, Gino Gerosa MD2, Alessandro Sticchi MD3,4, Antonio Marzocchi MD1, Ottavio Alfieri MD6, Antonio Colombo MD3,4 andFrancesco Saia MD, PhD1,*

Objectives: To compare the outcomes of trans-subclavian (TS) and transapical (TA) access for transcatheter aortic valve implantation (TAVI).

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of ultra-long second-generation drug-eluting stent implantation

Yohsuke Honda MD*, Toshiya Muramatsu MD, Yoshiaki Ito MD, Tsuyoshi Sakai MD, Keisuke Hirano MD, Masahiro Yamawaki MD, Motoharu Araki MD, Norihiro Kobayashi MD, Hideyuki Takimura MD, Yasunari Sakamoto MD, Shinsuke Mouri MD, Masakazu Tsutumi MD, Takuro Takama MD, Hiroya Takafuji MD, Takahiro Tokuda MD andKenji Makino MD

Objectives: This study investigated the safety and prognosis of ultra-long second DES (UL-2nd DES) implantation in real-world practice.

01 noviembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Palliative balloon pulmonary valvuloplasty for infants with unrestrictive ventricular septal defect or single ventricle associated with severe pulmonary stenosis

Ramiro W. Lizano Santamaria MD1, Matthew J. Gillespie MD1,2, Yoav Dori MD, PhD1,2, Jonathan J. Rome MD1,2 andAndrew C. Glatz MD, MSCE1,2,3,*

Background: Symptomatic infants with unrestrictive ventricular septal defect (VSD) or single ventricle with severe pulmonary stenosis (PS) are typically treated surgically. High surgical risk infants may benefit from catheter-based palliative pulmonary valvuloplasty.

15 noviembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. In-hospital mortality risk prediction after percutaneous coronary interventions: Validating and updating the toronto score in Brazil

Lucas Lodi-Junqueira MD, MSC, PhD1, José L.P. da Silva MSC2, Lorena R. Ferreira MD3, Humberto L. Gonçalves MD1, Guilherme R.S. Athayde MD1, Thalles O. Gomes MD1, Júlio C. Borges MD1, Bruno R. Nascimento MD, MSC, PhD1,3, Pedro A. Lemos MD, PhD4,* andAntônio L.P. Ribeiro MD, PhD3

Objectives: We aimed to assess the accuracy of the simple, contemporary and well-designed Toronto PCI mortality risk score in ICP-BR registry, the first Brazilian PCI multicenter registry with follow-up information.

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial

Carlos M. Campos MD1,2,†, Bojan M. Stanetic MD1,3,†, Vasim Farooq MD, PhD4, Simon Walsh MD5, Yuki Ishibashi MD, PhD1, Yoshinobu Onuma MD, PhD1, Hector M. Garcia-Garcia MD, PhD1, Javier Escaned MD, PhD6, Adrian Banning MD, PhD7, Patrick W. Serruys MD, PhD8,* andon behalf of the SYNTAX II Study Group

Background: Heart Team (HT) and the SYNTAX Score II (SSII) have been integrated to the contemporary guidelines with the aim to provide a multidisciplinary decision-making process between coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI).

01 diciembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications

Stefan H. Ostermayer MD1, Shubhika Srivastava MD1,*, John T. Doucette PhD2, H. Helen Ko RDCS1, Miwa Geiger MD1, Ira A. Parness MD1 andBarry A. Love MD1

Objectives: Assess impact of malattached septum primum (MASP) on transcatheter closure of interatrial communications.

05 enero 2016

CIRCULATION. Interventional Cardiology. Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease

Julien Adjedj, MD; Bernard De Bruyne, MD, PhD; Vincent Floré, MD, PhD; Giuseppe Di Gioia, MD; Angela Ferrara, MD; Mariano Pellicano, MD; Gabor G. Toth, MD; Jozef Bartunek, MD, PhD; Marc Vanderheyden, MD, PhD; Guy R. Heyndrickx, MD, PhD; William Wijns, MD, PhD; Emanuele Barbato, MD, PhD

Background: The fractional flow reserve (FFR) value of 0.75 has been validated against ischemic testing, whereas the FFR value of 0.80 has been widely accepted to guide clinical decision making. However, revascularization when FFR is 0.76 to 0.80, within the so-called gray zone, is still debatable.

06 octubre 2015

CIRCULATION. Interventional Cardiology. Influence of Sex on Long-Term Outcomes After Implantation of Bare-Metal Stent. A Multicenter Report From the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1

Kyohei Yamaji, MD; Hiroki Shiomi, MD; Takeshi Morimoto, MD; Toshiaki Toyota, MD; Koh Ono, MD; Yutaka Furukawa, MD; Yoshihisa Nakagawa, MD; Kazushige Kadota, MD; Kenji Ando, MD; Shinichi Shirai, MD; Masayuki Kato, MD; Yoshiki Takatsu, MD; Osamu Doi, MD; Hirofumi Kambara, MD; Satoru Suwa, MD; Tomoya Onodera, MD; Hirotoshi Watanabe, MD; Masahiro Natsuaki, MD; Takeshi Kimura, MD

Background: Female sex was reported to be associated with lower risk for midterm restenosis and repeat revascularization after bare-metal stent implantation. However, the influence of sex on very long-term outcomes after bare-metal stent implantation has not been yet reported.

18 septiembre 2015

CIRCULATION. Health Services and Outcomes Research. Association of Physician Certification in Interventional Cardiology With In-Hospital Outcomes of Percutaneous Coronary Intervention

Paul N. Fiorilli, MD; Karl E. Minges, MPH; Jeph Herrin, PhD; John C. Messenger, MD; Henry H. Ting, MD; Brahmajee K. Nallamothu, MD; Rebecca S. Lipner, PhD; Brian J. Hess, PhD; Eric S. Holmboe, MD; Joseph J. Brennan, MD; Jeptha P. Curtis, MD

Background: The value of American Board of Internal Medicine certification has been questioned. We evaluated the Association of Interventional Cardiology certification with in-hospital outcomes of patients undergoing percutaneous coronary intervention (PCI) in 2010.

19 octubre 2015

CIRCULATION. Congenital Heart Disease. Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization. A Report From the NCDR IMPACT Registry

Natalie Jayaram, MD, MSB; Robert H. Beekman III, MD; Lee Benson, MD; Ralf Holzer, MD; Kathy Jenkins, MD, MPH; Kevin F. Kennedy, MS; Gerard R. Martin, MD; John W. Moore, MD, MPH; Richard Ringel, MD; Jonathan Rome, MD; John A. Spertus, MD, MPH; Robert Vincent, MD; Lisa Bergersen, MD, MPH

Background: As US health care increasingly focuses on outcomes as a means for quantifying quality, there is a growing demand for risk models that can account for the variability of patients treated at different hospitals so that equitable comparisons between institutions can be made. We sought to apply aspects of prior risk-standardization methodology to begin development of a risk-standardization tool for the National Cardiovascular Data Registry (NCDR) IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry.

19 octubre 2015

CIRCULATION. Cardiovascular Surgery. Robotic Mitral Valve Repair for Simple and Complex Degenerative Disease. Midterm Clinical and Echocardiographic Quality Outcomes

Rakesh M. Suri, MD, DPhil; Amit Taggarse, MD; Harold M. Burkhart, MD; Richard C. Daly, MD; William Mauermann, MD; Rick A. Nishimura, MD; Zhuo Li, MSc; Joseph A. Dearani, MD; Hector I. Michelena, MD; Maurice Enriquez-Sarano, MD

Background: Severe primary (degenerative) mitral regurgitation (MR) is repaired with durable results when simple single-scallop disease is addressed. The midterm quality outcomes of minimally invasive repair for complex disease are unknown, however.

01 agosto 2015

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Coronary Interventions. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction

Petr Widimsky, MD, DrSc, Robert Petr, MD, Petr Tousek, MD, PhD, Martin Maly, MD, PhD, Hana Linkova, MD, PhD, Jiri Vrana, MD, Martin Hajsl, MD, Tomas Budesinsky, MD, Libor Lisa, MD and Viktor Kocka, MD, PhD

Background: Bioresorbable vascular scaffolds (BVS) represent promising new technology, but data on their long-term outcomes in ST-segment–elevation myocardial infarction (STEMI) setting are missing. The aim was to analyze 1-year clinical and computed tomographic angiographic outcomes after BVS implantation in STEMI.